Pascal Biosciences Inc. announced a private placement of 20,000,000 common shares at an issue price of CAD 0.10 per share for the gross proceeds of CAD 2,000,000 on June 30, 2023. All Shares have a hold period expiring November 1, 2023.

On same date, the company received 15,195,000 common shares at an issue price of CAD 0.10 per share for the gross proceeds of CAD 1,519,500 in its first tranche. 7,957,500 Share purchase warrants were issued to the subscribers to the private placement to acquire 7,957,500 additional Shares, exercisable for one year at a price of CAD 0.20 per share. A finder’s fee of CAD 74,550 was paid and the finder was issued 532,500 warrants on the same terms as the private placement warrants.